You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Coloma Jason V · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$53.04K
Coloma Jason V Chief Executive Officer
MAZE
Maze Therapeutics
MAZE
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
MAZE daily price context
Close on/before transaction
$25.57
Jun 22, 2026
First close after public filing
$27.02
Jun 25, 2026
30-day return after filing
+2.44%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,040 shares @ $26
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001676170-26-000012
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$725.49K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Sale | Jun 23, 2026 | $621.67K |
| Maze Therapeutics, Inc. MAZE | Sale | Jun 22, 2026 | $50.78K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Jun 22, 2026 | $53.04K |